证券记录 · 已归档季度
RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
12被追踪持有人
-1Δ持有人
25.35M持有股份
$62.12M报告持仓市值
+2新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -7.7% ·
股份流向 -30.0% ·
净新建仓位 -8.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 55.09M | $188.40M | +4 | −5 |
| Q1 2026 | 83 | +2 | 57.14M | $204.44M | +8 | −6 |
| Q4 2025 | 81 | +2 | 51.01M | $179.05M | +2 | — |
| Q3 2025 | 15 | 0 | 38.20M | $124.54M | — | — |
| Q2 2025 | 12 | -1 | 25.35M | $62.12M | +2 | −3 |
| Q1 2025 | 10 | -1 | 24.61M | $164.16M | +1 | −2 |
| Q4 2024 | 11 | 0 | 29.17M | $366.63M | +1 | −1 |
| Q3 2024 | 10 | 0 | 19.68M | $363.43M | +2 | −2 |
| Q2 2024 | 10 | — | 17.23M | $370.95M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (被动) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (被动) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (被动) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (被动) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (被动) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Millennium Management ✦ | 2.35M | +214.4% | $5.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (被动) | 2.03M | +1.9% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (被动) | 2.03M | +1.9% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (被动) | 1.94M | -47.5% | $4.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 1.73M | 新增 | $4.23M | 0.0% | New | 1 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 1.10M | -63.9% | $2.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 1.10M | -63.9% | $2.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 992.83K | 新增 | $2.43M | 0.0% | New | 1 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 992.83K | 新增 | $2.43M | 0.0% | New | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 35 | Renaissance Technologies ✦ | 461.37K | +36.3% | $1.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 266.05K | — | $651,819 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 266.05K | — | $651,819 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 156.05K | -89.7% | $382,322 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 156.05K | -89.7% | $382,322 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Two Sigma Investments | $4.23M | 0.0% |
| D. E. Shaw & Co. | $2.43M | 0.0% |
| D. E. Shaw & Co. | $2.43M | 0.0% |
已清仓
| Wellington Management | $84.22M | 曾为 0.0% |
| Marshall Wace | $2.93M | 曾为 0.0% |
| Norges Bank | $295,441 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 195 持有人, 96.37M 股份, $341.40M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 18
Shah Gaurav
Officer · 2.29K 股 · $7,753
Aug 18
Wilson Martin
Officer · 631 股 · $2,133
Aug 11
Chaudhuri Sarbani
Officer · 4.70K 股 · $16,449
Aug 11
Stevens Christopher James
Officer · 36.66K 股 · $128,266
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 31
SC 13G — VANGUARD PORTFOLIO MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据